Marblehead, MA, United States of America

Todd C Zion

USPTO Granted Patents = 47 


 

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 277(Granted Patents)


Location History:

  • Allston, MA (US) (2009)
  • Salem, MA (US) (2023)
  • Marblehead, MA (US) (2010 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
47 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Todd C. Zion in Diabetes Treatment

Introduction

Todd C. Zion, a notable inventor based in Marblehead, MA, has made significant strides in the field of diabetes treatment. With an impressive portfolio of 44 patents, his work primarily focuses on the development of ultra-long acting insulin-Fc fusion proteins, showcasing his dedication to enhancing diabetic care.

Latest Patents

Among his latest patents, Zion has developed remarkable formulations of insulin-Fc fusion proteins. One patent addresses a composition designed for the treatment of diabetes using ultra-long acting insulin-Fc fusion proteins. This innovative approach includes the creation of a recombinantly manufactured insulin-Fc fusion protein specifically aimed at treating canine diabetes. The compositions leverage a unique combination of an insulin polypeptide linked through peptide linkers to an Fc-fragment of canine origin. These formulations aim to provide a cost-effective treatment solution, maintaining in vivo bioactivity and avoiding the common issue of anti-drug antibodies, all while retaining potency across multiple administrations.

Career Highlights

Throughout his career, Todd C. Zion has collaborated with leading companies in the biotechnology sector, including Smartcells, Inc. and Akston Biosciences Corporation. His efforts in these organizations have been pivotal to the advancement and commercialization of innovative diabetes therapies.

Collaborations

Zion's work has not gone unnoticed, with significant collaboration with fellow researchers such as Thomas M. Lancaster and Thillainayagam Sathiyaseelan. Their combined expertise has facilitated the development of groundbreaking treatments for diabetes, further enhancing the potential impact of Zion's inventions in therapeutic applications.

Conclusion

In summary, Todd C. Zion's contributions to the field of diabetes treatment through his patents on ultra-long acting insulin-Fc fusion proteins mark him as an influential figure in innovative healthcare solutions. His dedication to advancing diabetic care continues to inspire progress in this critical field, offering hope for those affected by diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…